Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenac
Bromfenaco
Bromfenac sodium
Bromfenacum
Brand Names
Bromsite 0.075%
Bromfenac
Bromday
Xibrom
Pred-Brom
Apo-bromfenac
Pred Phos-Gati-Brom
Pred Phos - Brom
Bromfenac Ophthalmic Solution 0.09%
Bromfenac Sodium
Yellox
Pred-Gati-Brom
Bromfenac Ophthalmic Solution
Eugia-bromfenac
Prolensa
Bromfenac Ophthalmic Solution, 0.09%
Auro-bromfenac
Strenza Plus
Bromfenac 0.075%
Bromfenac Ophthalmic Solution, 0.07%
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682